Q3 2025 results and a corporate update
Quotation
“—————
We have an expected cash runway that provides nearly three years of capital with opportunities to expand it further without dilution and look forward to a rich calendar of anticipated clinical milestones and data events throughout 2026 and 2027.”
投資の参考になりましたか?

